Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2002 1
2003 1
2004 1
2012 1
2015 1
2016 1
2017 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial.
Karuturi M, Younes A, Fayad L, Kwak L, Pro B, Shah J, Oki Y, Simien R, Liboon MJ, Hutto T, Feng L, Horowitz S, Nieto Y, Anderlini P, Alousi A, Popat U, Medeiros LJ, Miranda R, Fanale M. Karuturi M, et al. Among authors: hutto t. Leuk Lymphoma. 2016 Feb;57(2):445-447. doi: 10.3109/10428194.2015.1032966. Epub 2015 Mar 25. Leuk Lymphoma. 2016. PMID: 25804933 Free PMC article. No abstract available.
Final results of a phase I and pharmacokinetic study of gamma-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors.
Johansen M, Zukowski T, Hoff PM, Newman RA, Ni D, Hutto T, Abbruzzeese J, Berghorn E, Hausheer F, Madden T. Johansen M, et al. Among authors: hutto t. Cancer Chemother Pharmacol. 2004 May;53(5):370-6. doi: 10.1007/s00280-003-0743-4. Epub 2003 Dec 18. Cancer Chemother Pharmacol. 2004. PMID: 15060739 Clinical Trial.